KWALITY PHARMACEUTICALS
Back to Cashflow Statement
|
KWALITY PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹7.04 Cr | ₹-14 Cr | ₹-17 Cr | ₹0.99 Cr | ₹5.66 Cr |
What is the latest Cash Flow from Financing Activities ratio of KWALITY PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹7.04 Cr |
| Mar2025 | ₹-14 Cr |
| Mar2024 | ₹-17 Cr |
| Mar2023 | ₹0.99 Cr |
| Mar2022 | ₹5.66 Cr |
How is Cash Flow from Financing Activities of KWALITY PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹7.04 Cr | Positive | |
| Mar2025 | ₹-14 Cr | Negative | |
| Mar2024 | ₹-17 Cr | Negative | |
| Mar2023 | ₹0.99 Cr | -82.43 | |
| Mar2022 | ₹5.66 Cr | - | |
Compare Cash Flow from Financing Activities of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹3,673.0 Cr | 4% | -5.9% | 327.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | 4% |
-5.9% |
327.7% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses